Clinical trial
Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study
NCT07521059 is registered in ClinicalTrials.gov with Vireo Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study
- Lead sponsor
- Vireo Systems, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 30, 2024
- Completion date
- October 1, 2024
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
safety of short term creatine hydrochloride dosing